Table 1.
AIS Group | HS Group | p | |
---|---|---|---|
(n = 200) | (n = 200) | ||
Demographics | |||
Age (years) | 73 (61–81) | 58 (50–67) | <0.001 |
Sex (male) | 120 (60) | 116 (58) | 0.760 |
Comorbidities | |||
Diabetes | 48 (24) | 15 (7.5) | <0.001 |
Hypertension | 156 (78) | 54 (27) | <0.001 |
Dyslipidemia | 86 (43) | 45 (22.5) | <0.001 |
Previous stroke | 42 (21) | 4 (2) | <0.001 |
Atrial fibrillation | 50 (25) | 8 (4) | <0.001 |
Cancer | 32 (16) | 28 (14) | 0.675 |
Hepatopathy | 7 (3.5) | 7 (3.5) | 1.000 |
Respiratory disease | 29 (14.5) | 10 (5) | 0.002 |
Obesity | 33 (16.5) | 41 (20.5) | 0.367 |
Pharmacological data | |||
Beta blockers | 87 (43.5) | 22 (11) | <0.001 |
Alpha blockers | 37 (18.5) | 9 (4.5) | <0.001 |
ACE inhibitors | 103 (51.5) | 30 (15) | <0.001 |
Sartans | 48 (24) | 22 (11) | 0.001 |
Calcium channel blockers | 74 (37) | 17 (8.5) | <0.001 |
Antidepressants | 12 (6) | 5 (2.5) | 0.135 |
Abbreviations: AIS, acute ischemic stroke; HS, healthy subjects Qualitative variables are expressed as absolute and relative percentage frequencies; quantitative data are presented as median and interquartile ranges.